Newsroom

29
May

MYOS Corporation Featured in Muscle & Fitness Magazine’s June Issue

UNLEASH YOUR POTENTIALThe limiting factor in your muscle growth may be high levels of myostatin.Written by Adam Gonzales (Muscle & Fitness, June 2014, pp. 159 - 160 ) When it comes to building muscle mass, most athletes and bodybuilders have the idea that they need more of everything: more training, more protein, more calories, and more supplements. While you certainly need to supply

28
May

MYOS Corporation to Present at the Third Annual Marcum MicroCap Conference

MYOS Corporation will be a featured presenter at the Third Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel. The Company’s presentation is scheduled to begin from 4:00 - 4:30 p.m. in Julliard Room. The annual Marcum MicroCap Conference is a signature showcase for superior quality,  public companies with under $500 million

27
May

Why MYOS? One-on-One With CMO Dr. Robert Ashton

Today we introduce Dr. Robert Ashton, Chief Medical Officer at MYOS Corporation. Ashton has an extensive background in general and thoracic surgery and focusing on cardiovascular disease, oncology, obesity, transplantation and chronic degenerative diseases. Over the course of his career, Ashton says, “I realized that muscle is really an important component to health in general, so I started

26
May

The Courage to Change the World

Too often, Memorial Day comes and goes without stopping to appreciate the source of sacrifice that has sustained our freedom at home and makes the defense of liberty around the globe possible. Theodore Roosevelt was likely thinking about this quality when he observed, “For those that will fight for it, life has a flavor the sheltered shall never know.” Of course Roosevelt was

23
May

The Life Sciences Report Interview With MYOS Chairman Robert J. Hariri

In a recent interview with George S. Mack of The Life Sciences Report, MYOS Executive Chairman Robert J. Hariri describes how his businesses address some of the great unmet needs in medicine. Hariri also discusses the special nature and advantages of placenta-derived stem cells, and an elegant solution to the scourge of muscle wasting in late-stage disease and advancing age that could apply to

21
May

MYOS Corp. announces appointment of DosSantos as new CFO

NJ Biz's Emily Bader covers MYOS Corp. appointment of DosSantos as new CFO.Cedar Knolls-based MYOS Corporation, a biotherapeutic and bionutrition company, announced Monday it has appointed Joseph C. DosSantos as chief financial officer. Click HERE to read more.

20
May

Why MYOS? One-on-One With President and COO Peter Levy

Today, we introduce you to MYOS President and Chief Operating Officer Peter Levy. Levy, who comes to MYOS Corporation with an impressive career as a practicing attorney, CPA firm partner, SEC integrity monitor and CEO of another publicly traded company, says the key reason he wanted to join the MYOS team is because of founder Dr. Robert Hariri. “Bob’s vision for MYOS, both in terms

28
April

MYOS Executive Chairman Robert Hariri, MD, PhD Responds to WSJ Article: “Drugs Aim to Help Elderly Rebuild Muscle”

The Wall Street Journal this morning released an article touting the significant developments being made in the field of myostatin inhibitors and muscle health research. MYOS Corporation, a bionutrition and biotherapeutics company, is a key player in the field of muscle health. In addition to focusing on the development and commercialization of products that improve the muscle function

09
April

Sarcopenia and the FDA: A Time for Change?

Rather than retrofit existing regulations, perhaps it’s time to start fresh, taking into account emerging science on muscle performance and it’s impact on healthy aging. There are many studies that show skeletal muscle strength is a good indication of overall health and well-being. Evidence of a product or activity that increases muscle strength is also pretty straightforward.

26
March

MYOS Board Member Peter Diamandis Named Top 50 Greatest Leaders by Fortune Magazine

MYOS Corporation board member and independent director Peter Diamandis, MD, was recently named one of the world’s top 50 greatest leaders by Fortune Magazine. Diamandis, who joined MYOS in 2011, is also Chairman and CEO of X PRIZE Foundation, a non-profit organization that creates large-scale incentivized prize competitions that lead to global innovations to benefit humanity.